Introduction
In 1965, Eger et al introduced the concept of minimum alveolar concentration (MAC), and it has since been used as the standard measure of potency for volatile anesthetic agents (see Image. Minimum Alveolar Concentration Dose Response). Previous attempts to create a measure to determine the adequacy of anesthetic dosings, such as the Guedel stages of anesthesia or Woodbridge concept of “nothing,” were all qualitative measures that varied depending on the inhaled anesthetics. The concept of MAC negated the variability by measuring a single quantitative endpoint: immobility. This condition is defined as the concentration of inhaled anesthetic within the alveoli at which 50% of people do not move in response to a surgical stimulus. MAC uses the measurement of end-tidal anesthetic as a measure of the level of anesthetic within the alveoli and, in turn, at the level of the central nervous system. This is a useful and reproducible metric in both animals and humans across all volatile anesthetics, making it the standard for comparison of volatile anesthetic potency.[1]
Function
Minimum alveolar concentration (MAC) provides a correlation between anesthetic dose and immobility. It can be applied to all inhalational anesthetics and is used to compare anesthetic potency.[2] Both animal and human studies have found that volatile anesthetics depress spinal motor-neuron excitability, which is why immobilization is mediated largely at the level of the spinal cord by inhaled anesthetics.[3] Immobilization is mediated by other aspects of anesthesia such as amnesia and hypnosis in the subcortical and cortical regions of the brain. Studies in rats demonstrated this concept by introducing lesions in the central nervous system to sever connections between the spinal cord and the brain, and it was found that these lesions did not alter MAC.[1]
Before the concept of MAC, the Meyer-Overton relationship was well established; it stated that all fat-soluble agents would function as anesthetics due to their ability to cross the lipid bilayer of neurons.[4] Although lipid solubility is not the sole determinant of potency, as proteins are likely the target site for volatile anesthetics, this concept holds true for volatile anesthetics. Following the Meyer-Overton theory, MAC could be estimated by using the following equation:
MAC x Lamda is about 1.82 atmospheres (atm), where Lamda equals the olive oil/gas partition coefficient for the volatile anesthetic.
[1]
Issues of Concern
Many variables alter the MAC changing the amount of anesthetic required to prevent movement. When a factor is present that increases MAC, there is a decreased potency of volatile anesthetic for that person, and they require a larger amount of anesthetic to achieve immobility. The inverse is true for factors that decrease MAC. The conventional values of MAC are determined at a reference pressure of 1 atm, and changes in ambient pressure will change MAC.[5]
Physiological Factors
Factors such as species, sex, hypothyroidism, hyperthyroidism, or duration of anesthesia do not affect MAC; however, the age of the patient does influence the minimum alveolar concentration. MAC peaks at 6 months of age, and then decreases by approximately 6% per decade, regardless of volatile anesthetic.[5] A comprehensive meta-analysis determined the relationship between MAC and age could be described with reasonable accuracy by the following equation:
MACage = MAC40 × 10^ [-0.00269(age - 40)], where MACage is the MAC at a given age and MAC40 is the MAC value at age 40.
[1]
Several physiological derangements, such as anemia, hypercarbia, and hypoxia, have been shown to decrease MAC.[1] Temperature is also a consideration that can influence the MAC of volatile anesthetics. MAC decreases with decreasing body temperature by approximately 4% to 5% with every decrease in degree centigrade. The anesthetic requirement continues to decrease in a linear fashion, with complete elimination of the need for anesthetic at 20 degrees Celcius. The opposite is true for hyperthermic patients, who have an increased MAC requirement. The exception to this is nitrous oxide (NO), as the MAC for NO does not change with decreasing temperature.[5] A special population to consider is those who are pregnant. Although the underlying cause is unclear, it has been found that MAC requirements are decreased during pregnancy by as much as 30%.[6] The increased potency of volatile anesthetics for this population also extends into the early postpartum period.[1] Interestingly, it has been found that individuals with red hair have a decreased sensitivity to anesthetics, and have an increased MAC requirement.[7]
Pharmacological Factors
Many pharmacological agents alter MAC. Commonly used classes of drugs in anesthesia, such as sedative-hypnotic agents, intravenous drugs that potentiate gamma-aminobutyric acid, a2-adrenergic agonists, local anesthetics, and opioids, all decrease MAC. These include medications such as barbiturates, benzodiazepines, propofol, etomidate, and dexmedetomidine. A decrease in MAC requirement is also seen with ketamine, lithium, and verapamil.[1] Stimulants such as cocaine and ephedrine increase MAC. Substances such as alcohol and amphetamines depend on the chronicity of use. Chronic alcohol use and acute amphetamine use increase the MAC requirement, while the inverse decreases the MAC requirement.
Pathologic Factors
Patients presenting with a depressed level of consciousness due to trauma or a cerebrovascular insult, or patients with neurodegenerative changes due to dementia or other cognitive conditions have a decreased anesthetic requirement.[1] Hypoxia below 30 mm Hg, acute metabolic acidosis, and acute hemorrhagic hypotension all produce decreases in roughly 10% to 50% of initial MAC.[2] Certain electrolyte abnormalities, such as hypernatremia, are associated with an increase in MAC, while hyponatremia is associated with a decrease in MAC.
Clinical Significance
Minimum alveolar concentration (MAC) and lipid solubility vary among different volatile anesthetics. The most commonly used anesthetics follow the order of nitrous oxide > desflurane > sevoflurane > isoflurane > halothane, for highest to lowest MAC. This order follows the Meyer-Overton rule and has a direct correlation with the oil/gas partition coefficient.[4] When combining inhaled anesthetics, it is important to note that there is a roughly additive effect for MAC.[5] For example, 0.5 MAC of nitrous oxide (54%) combined with 0.5 MAC with sevoflurane (1%), will have the clinical effect of 1 MAC of any volatile anesthetic.
When looking at a normal distribution, MAC represents one point on the dose-response curve and is the equivalent of a median effective dose (ED50). In addition, the standard deviation (SD) of MAC is approximately 10%. Following the properties of a normal distribution, MAC + 1 SD (1.1 MAC), would produce immobility in roughly 68% of the population, and MAC + 2 SDs (1.2 MAC) should produce immobility in approximately 95% of patients.[1] Providers can use these principles to titrate their anesthetics appropriately. Besides immobility, MAC can be used clinically to assess unconsciousness, amnesia, eye-opening, and autonomic response, using the concepts of MAC-awake, MAC-amnesia, and MAC-bar. MAC-awake is defined as the anesthetic concentration needed to suppress a voluntary response to verbal command (ie, eye-opening) in 50% of patients.[5] It is generally one-third of MAC for the inhaled anesthetic being used.
MAC-amnesia is the anesthesia concentration required to suppress recollection or explicit memory of a noxious stimulus. Within the brain, volatile anesthetics act on the amygdala, hippocampus, and cortex, which are responsible for the formation of explicit episodic memory. Anterograde amnesia is achieved at roughly 0.25 MAC, compared to unconsciousness, which is generally achieved at 0.5 MAC.[1] The MAC for endotracheal intubation (MACEI) is defined as the end-tidal concentration of inhaled anesthetic agents at which 50% of patients can be intubated smoothly. The MACEI/MAC ratio for sevoflurane is about 1.3 in children and 3 in adults. Thus, if only inhaled anesthetic agents are used in adults, intubation will require a very high concentration of volatile agents which might result in hemodynamic instability. So, muscle relaxants and opioids are used to facilitate intubation as a part of balanced anesthesia. The concept of MAC-bar is an estimate of the MAC of volatile anesthetic that blocks autonomic responses to surgical incisions in 50% of patients. The autonomic responses commonly used to define MAC-bar are changes in pupil dilation, heart rate, and blood pressure.[1] MAC-BAR was determined by measuring the level of catecholamine in venous blood and has been calculated to be roughly 1.5 MAC.
Other Issues
One of the major limitations of MAC is that it is not applicable when administering total intravenous anesthesia. Furthermore, in clinical practice, it is common to administer balanced anesthesia, including the use of neuromuscular blockade, intravenous anesthesia, and opioids. While these drugs tend to decrease MAC, they may not equally affect MAC-awake or MAC-amnesia. Therefore, MAC cannot be used as the sole measure of anesthetic effect.[1]
Enhancing Healthcare Team Outcomes
Minimum alveolar concentration can be used to titrate the level of volatile anesthetic to achieve and maintain a safe level of anesthesia. This concept is used routinely by all anesthesia providers and is imperative for patient safety, decreased awareness, and patient comfort.
Minimum Alveolar Concentration Dose Response. The graph illustrates the dose response in minimum alveolar concentration, the standard measure of potency for volatile anesthetic agents. Contributed by S Bhimji, MD
References
- 1.
Aranake A, Mashour GA, Avidan MS. Minimum alveolar concentration: ongoing relevance and clinical utility.
Anaesthesia. 2013 May;68(5):512-22. [
PubMed: 23414556]
- 2.
Eger EI, Saidman LJ, Brandstater B. Minimum alveolar anesthetic concentration: a standard of anesthetic potency.
Anesthesiology. 1965 Nov-Dec;26(6):756-63. [
PubMed: 5844267]
- 3.
Sonner JM, Antognini JF, Dutton RC, Flood P, Gray AT, Harris RA, Homanics GE, Kendig J, Orser B, Raines DE, Trudell J, Vissel B, Eger EI. Inhaled anesthetics and immobility: mechanisms, mysteries, and minimum alveolar anesthetic concentration.
Anesth Analg. 2003 Sep;97(3):718-740. [
PubMed: 12933393]
- 4.
Alkire MT, Gorski LA. Relative amnesic potency of five inhalational anesthetics follows the Meyer-Overton rule.
Anesthesiology. 2004 Aug;101(2):417-29. [
PubMed: 15277925]
- 5.
Eger EI. Age, minimum alveolar anesthetic concentration, and minimum alveolar anesthetic concentration-awake.
Anesth Analg. 2001 Oct;93(4):947-53. [
PubMed: 11574362]
- 6.
Chan MT, Mainland P, Gin T. Minimum alveolar concentration of halothane and enflurane are decreased in early pregnancy.
Anesthesiology. 1996 Oct;85(4):782-6. [
PubMed: 8873548]
- 7.
Zdrojewicz Z, Kowalik M, Jagodziński A. [Secrets of the red-headed].
Pol Merkur Lekarski. 2016 Dec 22;41(246):306-309. [
PubMed: 28024137]
Disclosure: Sharlene Lobo declares no relevant financial relationships with ineligible companies.
Disclosure: Juan Ojeda declares no relevant financial relationships with ineligible companies.
Disclosure: Anterpreet Dua declares no relevant financial relationships with ineligible companies.
Disclosure: Karampal Singh declares no relevant financial relationships with ineligible companies.
Disclosure: Javier Lopez declares no relevant financial relationships with ineligible companies.
